Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study-Reference-Cited by-同舟云学术

Safety profile of the SQ house dust mite sublingual immunotherapy-tablet in Japanese adult patients with house dust mite-induced allergic asthma: a randomized, double-blind, placebo-controlled phase I study

Published:2018-11-16 Issue:12 Volume:56 Page:1347-1355
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Okamiya Kazuhiro¹,Sekino Hisakuni²,Azuma Ryuji¹,Kudo Minoru¹,Sakaguchi Miyuki¹,Nemoto Fumi¹,Muramatsu Naoki¹,Maekawa Yuriko¹,Tanaka Akihiko³

Affiliation:

1. Torii Pharmaceutical Co. Ltd., Tokyo, Japan;

2. Department of Internal Medicine, Sekino Hospital, Tokyo, Japan;

3. Department of Medicine, Division of Respiratory Medicine and Allergology, School of Medicine, Showa University, Tokyo, Japan

Funder

Torii Pharmaceutical Co. Ltd.

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2018.1541353

Reference21 articles.

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2017. Available from: http://ginasthma.org [Accessed 5 Apr 2018].

2. The global burden of asthma: executive summary of the GINA Dissemination Committee Report

3. Time Trend in the Prevalence of Adult Asthma in Japan: Findings from Population-Based Surveys in Fujieda City in 1985,1999, and 2006

4. Nationwide Cross-Sectional Population-Based Study on the Prevalences of Asthma and Asthma Symptoms among Japanese Adults

5. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. House dust mite immunotherapy: A real‐world, prescription data‐based analysis;Clinical and Translational Allergy;2024-07

2. CD44 is critical for the enhancing effect of hyaluronan in allergen-specific sublingual immunotherapy in a murine model of chronic asthma;Clinical and Experimental Immunology;2022-03-07

3. Guideline on allergen immunotherapy in IgE-mediated allergic diseases;Allergologie select;2022-01-01

4. Sublingual immunotherapy for asthma;Cochrane Database of Systematic Reviews;2020-09-14

5. Efficacy and Safety of HDM SLIT Tablet in Japanese Adults with Allergic Asthma;The Journal of Allergy and Clinical Immunology: In Practice;2020-02